
Windtree Therapeutics Skyrockets on Game-Changing Patent for Heart Failure Drug
Alright, folks, let’s talk about a stock that’s got the market buzzing like a beehive at a picnic—Windtree Therapeutics, Inc. (NASDAQ: WINT)! As of this writing, WINT is up a jaw-dropping 39.55% in pre-market trading, and it’s no surprise why. The company …